Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

$3 Billion Autoimmune Disease Diagnosis Market, 2022 by Products, Test Type, Disease & End Users - ResearchAndMarkets.com

Research and Markets
Posted on: 06 Mar 18

The "Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The Global Autoimmune Disease Diagnosis Market is Expected to Reach US$4.73 Billion By 2022, from US$3.09 Billion in 2017, at a CAGR of 8.9%.

Factors driving the growth of this market include the rising incidence of autoimmune diseases, growing healthcare expenditure, increasing access to medical insurance in the US, and technological advancements in diagnosis devices. On the other hand, the high cost of analyzers and other instruments is expected to challenge market growth to a certain extent.

The autoimmune disease diagnosis market by product and service is categorized into consumables & assay kits, instruments, and services. The consumables and assay kits segment is expected to register the highest CAGR during the forecast period. The growing adoption of consumables and assay kits for the diagnosis of autoimmune diseases is the key factors driving the growth of this market.

The autoimmune disease diagnosis market by test type is categorized into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory test segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the increasing adoption of routine laboratory tests for a variety of diseases.

The autoimmune disease diagnosis market by disease is categorized into systemic lupus erythematosus, rheumatoid arthritis, Sjgren's syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid arthritis segment is expected to register the highest CAGR during the forecast period. The growing use of instruments and consumables for the diagnosis and treatment of rheumatoid arthritis, increasing awareness regarding autoimmune diseases, and the development of novel products are the key factors driving the growth of this market.

By end user, the autoimmune disease diagnosis market is segmented into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is expected to grow at the highest CAGR during the forecast period. Factors such as the rising number of patients suffering from autoimmune diseases and improving healthcare infrastructure are driving the growth of this segment.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Autoimmune Disease Diagnosis Market, By Product & Service

7 Autoimmune Disease Diagnosis Market, By Test Type

8 Autoimmune Disease Diagnosis Market, By Disease

9 Autoimmune Disease Diagnosis Market, By End User

10 Autoimmune Disease Diagnosis Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Abbott
  • Bio-Rad Laboratories
  • Danaher
  • Euroimmun
  • GRIFOLS
  • HYCOR Biomedical
  • Inova Diagnostics
  • Protagen
  • Siemens
  • Thermo Fisher Scientific
  • Trinity Biotech

For more information about this report visit https://www.researchandmarkets.com/research/trwcjh/3_billion?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180306005956/en/

Business Wire
www.businesswire.com

Last updated on: 06/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.